Clinical Trials Logo

Filter by:
NCT ID: NCT01631604 Active, not recruiting - Clinical trials for Neurological Conditions

Gait Characteristics Following a Fall

Start date: June 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

NCT ID: NCT01631578 Withdrawn - Low Ovarian Reserve Clinical Trials

Improving the Reproductive Outcome of Poor Quality Ova by Injection of Autologous Somatic Mitochondria

Start date: January 2012
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective randomized controlled trial (RCT) to determine the effect of injecting an autologous somatic mitochondria concentrate, together with the spermatozoon during ICSI, into oocytes of older and or poor prognosis in vitro fertilization (IVF) patients.

NCT ID: NCT01631396 Completed - Surgery Clinical Trials

Comparison of Two Neuromuscular Anesthetics Reversal in Obese Patient Undergoing Bariatric Surgery

Start date: July 2012
Phase: N/A
Study type: Observational

The study is a prospective, single center, double arm study aiming at the comparison of 2 commercial neuromuscular block reversal drugs: Neostigmine (Cooper S.A.) and Sugammadex (MSD). A faster recovery from neuromuscular block is expected for patients receiving Sugammadex and this protocol is of high importance for anesthesia of morbid obese patients during bariatric surgery.

NCT ID: NCT01631344 Completed - Low Back Pain Clinical Trials

Effectiveness of Lifestyle Counseling Versus Physical Therapy on Chronic Low Back Pain

Start date: February 2011
Phase: N/A
Study type: Interventional

Background: Low back pain is the leading cause of disability, affecting the quality of life and work productivity. It is the most common reason for seek medical help and advice. Low back pain creates huge economical burden worldwide. To date, most ( 90%) of low back pain cases are not clinically defined with no preferred medical treatment 1. Study objectives: To prove that consulting using the "Stage of change" model for daily physical activity will lead to long term improvement of pain, disability and well-being parameters of those suffering from chronic low back pain, people age 25-55, when compared to conventional Physical Therapy. 2. Study hypotheses: The intervention groups vs. Physical Therapy group will demonstrate that the following parameters will improve after: 3 months, one, two and five years. 1. Pain reduction. 2. Less disability - improvement in daily activities. 3. Better feeling of health and well-being. 4. Increased and better compliance to daily sport activities. 5. BMI reduction. 6. Reduction of cigarette smoking. 7. Reduction of usage of anti-analgesics and anti-inflammatory medications. 8. Reduction in number of visits to Physical Therapy clinics due to low back pain. 3. Methods: The present Randomized intervention study that will include 220 healthy individuals, males and females aged 25-55 years old suffering from chronic or recurrent low back pain, with or without radiation to the legs that were referred to Maccabi Healthcare Services Physical Therapy clinics in the Sharon district in Israel. These individuals will be randomized to one of the following two groups: 1. Conventional Physical Therapy. 2. Physical Therapy focused on healthy lifestyle using the "Stage of Change" model. Non-dependent observer will follow-up on the outcome parameters via phone calls and filling the questionnaire's with the relevant study participants following 3 months, 1 year, 2 and 5 years.

NCT ID: NCT01631214 Completed - Clinical trials for Postmenopausal Women With Osteoporosis

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

ARCH
Start date: May 4, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if treatment is effective in preventing fractures in women with postmenopausal osteoporosis.

NCT ID: NCT01631162 Recruiting - Asthma Clinical Trials

The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples

PHNOSE
Start date: May 2012
Phase: N/A
Study type: Interventional

The investigators assume that by analysis of different volatile organic compounds in the breath, using nanotechnology, the investigators will be able to identify a unique respiratory signature of different diseases including asthma, chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.

NCT ID: NCT01630733 Recruiting - Clinical trials for Non-Small Cell Lung Cancer

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

Start date: September 2012
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to compare overall survival of patients randomized to receiving custirsen in combination with docetaxel (Arm A) with patients randomized to receive docetaxel alone (Arm B).

NCT ID: NCT01630603 Recruiting - Clinical trials for Maternal Vitamin D Status

Maternal Vitamin D Status and Neonatal Bone Strength

Vitamin D
Start date: July 2012
Phase: N/A
Study type: Observational

Objectives: 1. To determine the incidence of vitamin D deficiency among Israeli pregnant women 2. To access whether maternal vitamin D status affects infant bone strength. Methods: 1. Vitamin D levels -in cord blood and maternal blood 2. The mother will fill a demographic and nutritional questionnaire The Infants: 3. Growth assessment of the infants: weight length and head circumference 4. Bone strength measurement by Quantitative Ultrasound (Sunlight Omnisense 7000/8000TM)

NCT ID: NCT01629667 Terminated - Clinical trials for Idiopathic Pulmonary Fibrosis

A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis

Start date: October 2012
Phase: Phase 2
Study type: Interventional

To study the safety and effectiveness of multiple-doses of tralokinumab on pulmonary function in adults with mild to moderate idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive, irreversible, and usually fatal lung disease of unknown cause.

NCT ID: NCT01629628 Not yet recruiting - Crohn Disease Clinical Trials

Adalimumab for the Management of Post-operative Crohn's Disease (CD)

POPART
Start date: July 2012
Phase: Phase 3
Study type: Interventional

This study will be a prospective, open label, randomized, comparative study. Comparing the efficacy of adalimumab with immunomodulator therapy (i.e. 6-mercaptopurine, 6-MP), in maintaining remission of post-operative CD patients, with a high risk of disease recurrence. Patient assessment for efficacy will be conducted through interval endoscopic surveillance at 24 and 52 weeks. Patients in the adalimumab arm, showing endoscopic remission at 52 weeks of therapy, will be re-randomized to either maintain adalimumab therapy for an additional 52 weeks or conclude therapy. A third endoscopic assessment for these patients will be conducted at 104 weeks. The investigators expect a substantial increase in both endoscopic, as well as clinical remission rate in patients on adalimumab therapy.